Midatech Pharma US Inc. - Strategic SWOT Analysis Review

Midatech Pharma US Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Midatech Pharma US Inc. (Midatech Pharma) formerly known as Dara BioSciences, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of cancer treatment and supportive care products. The company’s product portfolio includes Soltamox, for the treatment of breast cancer; Gelclair, a treatment of oral mucositis; Oravig, for the treatment of OPC in adults; Ferralet 90, for the treatment of all anemias; and Aquoral, is an oral spray used for the treatment of dry mouth. Its product pipeline comprises KRN5500, for the treatment of neuropathic pain. The company collaborates with pharmaceutical companies such as Mission Pharmacal to develop and commercialize its product candidates. It distributes its products through retail pharmacies, mail order pharmacies, and long-term care facilities. Midatech Pharma is headquartered in North Carolina, the US.

Midatech Pharma US Inc. Key Recent Developments

Nov 02, 2015: DARA BioSciences Announces Third Quarter 2015 Results
Aug 12, 2015: DARA BioSciences Announces Second Quarter 2015 Results
May 13, 2015: DARA BioSciences Announces First Quarter 2015 Results
Mar 03, 2015: Dara BioSciences Announces Fourth Quarter and Full Year 2014 Results
Jan 06, 2015: DARA BioSciences Granted Waiver of Product and Establishment Fees by the FDA

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Frequently Asked Questions